GP-Act III Acquisition Corp. $GPAT Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in GP-Act III Acquisition Corp. (NASDAQ:GPAT) by 28.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 250,000 shares of the company’s stock after selling 100,000 shares during the period. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in GP-Act III Acquisition were worth $2,675,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in GPAT. Linden Advisors LP acquired a new position in shares of GP-Act III Acquisition in the third quarter valued at approximately $8,454,000. TENOR CAPITAL MANAGEMENT Co. L.P. acquired a new position in shares of GP-Act III Acquisition in the second quarter valued at approximately $7,800,000. L1 Global Manager Pty Ltd acquired a new position in shares of GP-Act III Acquisition in the fourth quarter valued at approximately $6,067,000. Radcliffe Capital Management L.P. grew its holdings in shares of GP-Act III Acquisition by 287.8% in the third quarter. Radcliffe Capital Management L.P. now owns 572,895 shares of the company’s stock valued at $6,073,000 after purchasing an additional 425,152 shares in the last quarter. Finally, Westchester Capital Management LLC grew its holdings in GP-Act III Acquisition by 22.5% during the 4th quarter. Westchester Capital Management LLC now owns 1,360,852 shares of the company’s stock worth $14,561,000 after acquiring an additional 250,000 shares in the last quarter.

GP-Act III Acquisition Trading Up 0.7%

NASDAQ GPAT opened at $10.92 on Tuesday. GP-Act III Acquisition Corp. has a 52 week low of $10.50 and a 52 week high of $12.00. The firm has a 50 day moving average of $10.88 and a two-hundred day moving average of $10.79.

GP-Act III Acquisition (NASDAQ:GPAT) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.06 EPS for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

GP-Act III Acquisition Profile

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.